
-
Australia's Hazlewood steers Bengaluru win over Rajasthan
-
Trump says pressuring Russia, claims concessions
-
Trump tariff talks are prolonging uncertainty: S.Africa central bank chair
-
Multitudes line up for second day to view pope
-
Grief and discontent as Armenia marks WWI mass murders anniversary
-
Dallas coach Kidd joins Everton ownership group
-
Israel army warns of 'larger' Gaza assault as strikes kill 55
-
Pupil kills fellow student in France school knife attack
-
Vatican releases details of Pope Francis's marble tomb
-
Gaza rescuers say Israeli strikes kill 53
-
Corona beer maker Modelo says to invest $3.6 bn in Mexico
-
American Airlines pulls 2025 forecast on economic uncertainty
-
Swiatek survives Eala scare to start Madrid Open defence
-
Stocks rally rolls on in US, fizzles elsewhere
-
France failed to protect rights of teen rape victims: Europe court
-
European carmakers on China charm offensive as sales droop
-
Rampaging Marquez hungry for more as MotoGP heads to Spain
-
Trump should be 'free' to criticize the Fed, senior official says
-
Trump slams Harvard as funding fight heads to court
-
Student kills classmate in France knife attack: police source
-
US existing home sales see biggest drop since 2022
-
'Made in America' lingerie squeezed by Trump's tariffs
-
'Vladimir, STOP!': Trump turns on Putin after deadly Kyiv strike
-
French independent studio's first video game draws fans
-
US Treasury chief raised 'important issues' in IMF criticism: Georgieva
-
US existing home sales retreat more than expected in March
-
Stocks rally fades along with hopes of quick US-China trade deal
-
Warning lights flash at Nissan after monster profit warning
-
Hundreds protest in Pakistan over India's threats
-
P&G cuts outlook as consumers pull back amid tariffs
-
US opposes 'dangerous' anti-fossil fuel policies at global summit
-
Favourite KAJ hopes for fun and steamy Eurovision
-
India PM vows to pursue Kashmir attackers to 'ends of the Earth'
-
Pope's death sparks betting frenzy for successor
-
Germany expects zero GDP growth this year, blames Trump tariffs
-
'Greatest-ever' Vardy to leave Leicester at end of season
-
'They want to destroy us': Kyiv hit in biggest Russian attack in months
-
Nissan forecasts huge annual net loss of up to $5.3 bn
-
Stock markets mostly fall as hopes of US-China trade deal dampen
-
Alcaraz withdraws from Madrid Open with injury
-
Furious India eyes response to Pakistan after Kashmir attack
-
Africans eye a pope from among their own
-
Three Chinese astronauts blast off for Tiangong space station
-
Newcastle boss Howe returns to work after pneumonia
-
Asian markets mixed as China dispels Trump talk of tariff negotiations
-
Countries could use forests to 'mask' needed emission cuts: report
-
Zelensky cuts short South Africa trip after deadly attack on Kyiv
-
Sri Lanka Buddhists overwhelm city in bid to see sacred tooth
-
Thousands gather for second day to view pope
-
Teenage suspect in attack on rabbi sentenced to 16 months in prison

A New Era in Patient Affordability: TailorMed Builds the Industry Infrastructure to Tackle Medication Costs at Scale
Facing Soaring Drug Prices, TailorMed's Affordability Network Bridges Care and Financial Relief
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Millions of Americans today face an impossible choice between affording life-saving medications and risking severe financial hardship. TailorMed is tackling this challenge by bringing healthcare providers, specialty pharmacies, life science companies, and patients together in one coordinated network - streamlining access to financial assistance so patients can stay on-therapy and achieve better outcomes.
On April 29, at 4:00 p.m. PT during Asembia AXS25, TailorMed CEO and co-founder Srulik Dvorsky will moderate "It Takes a Network: Tackling Affordability Together," joined by senior leaders from Pfizer, Walgreens Specialty Pharmacy, MetroHealth, and Pink Fund. This strategic roundtable will demonstrate how TailorMed's collaborative network turns these partnerships into real-world solutions that ease patient financial burdens and improve care.
"The soaring cost of medications is creating an untenable situation for patients, forcing too many to choose financial stability over essential treatments," said Dvorsky. "Our colleagues at Pfizer, Walgreens, Pink Fund, and MetroHealth share our passion and recognize the need to fundamentally change how affordability is managed, and ensure patients can access vital treatments without financial hardship. We are grateful that our partners will join this panel discussion to share their expertise."
TailorMed's extensive affordability network, the largest of its kind, ensures patients find the care pathways they need, when they need them. By bringing together healthcare providers, specialty pharmacies, life science companies, and nonprofit organizations, TailorMed leverages cutting-edge technology and collaborative partnerships to eliminate financial barriers, dramatically improving patient outcomes and easing systemic healthcare burdens.
TailorMed representatives will also be available throughout the summit at booth #2014 for discussions and demonstrations of their affordability solutions.
For additional information on TailorMed's innovative approaches to medication affordability, visit https://tailormed.co/.
About TailorMed
TailorMed is a comprehensive platform dedicated to removing financial barriers across the medication continuum - from affordability and access to adherence. TailorMed transforms healthcare collaboration among patients, providers, pharmacies, life sciences companies, and payers, ensuring every patient receives the treatments they need promptly. With the nation's largest Affordability Network deployed in more than 800 hospitals, 1,300 clinics, and 1,400 pharmacies, TailorMed enables stakeholders to deliver seamless patient experiences and drive better healthcare outcomes. Learn more at tailormed.co.
Media Contact:
Jennifer Martin, VP, Marketing
312.882.4402 | [email protected]
PR Contact:
Glenn Goldberg
Parallel Communications Group
+1 516 776-3282
LinkedIn
𝕏: @Parallel_PR
[email protected]
SOURCE: TailorMed
View the original press release on ACCESS Newswire
B.Finley--AMWN